Arduino Samorì

Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry

Massimo Offidani, Laura Corvatta, Claudia Polloni et al. · Clinical Lymphoma Myeloma & Leukemia · 2012 · 43 citations

Medicine, Biostatistics, Oncology +11

Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide

Massimo Offidani, Laura Corvatta, Claudia Polloni et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +14

Thalidomide‐dexamethasone <i>versus</i> Interferon‐alpha‐dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study

Massimo Offidani, Laura Corvatta, Claudia Polloni et al. · British Journal of Haematology · 2008 · 28 citations

Medicine, Hematology, Oncology +13

Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed–refractory multiple myeloma

Massimo Offidani, Laura Corvatta, Claudia Polloni et al. · Annals of Hematology · 2011 · 18 citations

Medicine, Hematology, Pharmacology +14

ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with <i>de novo</i> multiple myeloma

Massimo Offidani, Pietro Leoni, Laura Corvatta et al. · European Journal Of Haematology · 2010 · 18 citations

Medicine, Hematology, Pharmacotherapy +14